Skip to main content

Livonia Pharmacy and Pharmacist Summarily Suspended for Over Dispensing Controlled Substances

Media Contact: LARA Communications 517-373-9280

December 8, 2017 – The Dept. of Licensing and Regulatory Affairs (LARA) served orders summarily suspending the controlled substance license of Livonia Care Pharmacy, Inc. in Livonia and the pharmacist license of Apoorva Pandit, who is responsible for Livonia Care’s compliance with the Public Health Code. The Michigan Public Health Code provides for summary suspension of licenses when the public health, safety, or welfare requires emergency action.

LARA also served accompanying administrative complaints on Livonia Care and Pandit detailing their alleged dispensing of controlled substances without good faith and a failure to maintain effective controls against the diversion.

LARA’s complaint indicates that Livonia Care was among Michigan’s highest-volume dispensers of commonly abused and diverted medications, such as promethazine with codeine cough syrup and soma, a muscle relaxant. According to the complaint, Livonia Care dispensed dangerous combinations of drugs to patients, including multiple patients who traveled a significant distance to fill their prescriptions.

Governor Rick Snyder’s Michigan Prescription Drug and Opioid Abuse Task Force called for a more comprehensive enforcement program against licensed health professionals and facilities who participate in overprescribing and over dispensing.  Accordingly, LARA created a permanent Drug Monitoring Section which focuses on identifying, investigating, and pursuing appropriate disciplinary actions against individuals who overprescribe or divert controlled substances, and individuals and facilities who over dispense controlled substances.

An order of summary suspension is a temporary measure to protect the public and not a final determination that a licensee has violated the Public Health Code.

For more information of LARA’s regulation of health professions in Michigan, please go to

For more information about LARA, please visit

Follow us on Twitter at or “Like” us on Facebook